CLINICAL TRIAL
Published on 27 Sep 2021
Efficacy of Sertraline Plus Placebo or Add-On Celecoxib in Major Depressive Disorder: Macrophage Migration Inhibitory Factor as a Promising Biomarker for Remission After Sertraline—Results From a Randomized Controlled Clinical Trial
doi 10.3389/fpsyt.2021.615261
- 3,387 views
- 16 citations